STAAR Surgical Taps COO and CFO as Interim Co-CEOs Following Leadership Transition

STAAR Surgical Company (STAA), a leading manufacturer of implantable intraocular lenses for vision correction, has unveiled its new interim leadership structure. The medical device firm has named its Chief Operating Officer Warren Foust and Chief Financial Officer Deborah Andrews to jointly serve as interim Co-CEOs, with the arrangement taking effect on February 1.

Two Executives Named to Co-Lead the Medical Device Maker

The appointment of these two senior executives comes following the departure of the previous CEO in January. Both Foust and Andrews bring substantial operational and financial expertise to the organization. Foust’s background in operations management positions him to oversee day-to-day business execution, while Andrews’ financial acumen ensures continuity in the company’s fiscal strategy during this transitional period. This dual-leadership model reflects the company’s effort to maintain stability while navigating the executive transition.

Ongoing Search for Permanent CEO Leadership

According to company disclosures, a dedicated search committee has been established to identify a permanent Chief Executive Officer. The recruitment effort is evaluating both internal candidates already within the organization and external candidates from the broader industry. The comprehensive approach demonstrates the company’s commitment to finding qualified leadership that aligns with STAAR Surgical’s strategic vision and market positioning.

Market Response and Stock Performance

Investor sentiment reflected modest stability as STAA shares closed at $18.95, representing a slight gain of 0.05% on the Nasdaq exchange. The market’s measured response suggests investors are taking a wait-and-see approach regarding the interim leadership arrangement and the ongoing CEO recruitment process.

The interim co-CEO structure represents a strategic decision to maintain operational continuity while the company pursues its permanent CEO selection, ensuring both COO-level operational oversight and CFO-level financial stewardship during this critical transition phase.